Approved February 1999
Cancer & Oncology
UVADEX (methoxsalen) Sterile Solution with the UVAR® Photopheresis System has been approved for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
The UVADEX Sterile Solution drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.